Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AXSM
AXSM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AXSM News
Healthcare Transformation: The Rise of Data-Driven Models
2d ago
Fool
Tempus AI and Others Poised to Transform Precision Medicine
2d ago
NASDAQ.COM
Potential Analysis of Small Biotech Stocks
5d ago
Fool
Axsome Therapeutics Q1 2026 Earnings Call Highlights
6d ago
seekingalpha
Axsome Therapeutics Shares Surge on FDA Approval and Strong Pipeline
6d ago
Fool
Amazon Launches Supply Chain Services, Pressuring Logistics Stocks
6d ago
CNBC
AXSOME THERAPEUTICS STOCK JUMPS 10.7% FOLLOWING INCREASED Q1 REVENUE
6d ago
moomoo
Axsome Therapeutics Q1 Sales Exceed Expectations
6d ago
stocktwits
GameStop Proposes $55.5 Billion eBay Acquisition, Shares Surge
6d ago
CNBC
Axsome Therapeutics Q1 Earnings Beat Expectations with Strong Revenue Growth
6d ago
seekingalpha
AXSOME THERAPEUTICS INC: NEEDHAM INCREASES TARGET PRICE FROM $225 TO $255
6d ago
moomoo
Axsome Therapeutics Sees Significant Sales Growth
May 02 2026
Fool
Axsome Therapeutics to Announce Q1 Earnings on May 4th
May 01 2026
seekingalpha
FDA Approves Axsome's Auvelity for Alzheimer's Agitation
May 01 2026
Newsfilter
FDA Approves Axsome's Auvelity for Alzheimer's Agitation Treatment
May 01 2026
seekingalpha
Axsome Therapeutics Receives FDA Approval for AUVELITY in Alzheimer's Agitation
May 01 2026
Newsfilter
Show More News
